Hellstrand K, Asea A, Hermodsson S
Department of Clinical Virology, University of Göteborg, Sweden.
Clin Diagn Lab Immunol. 1995 May;2(3):277-80. doi: 10.1128/cdli.2.3.277-280.1995.
Depletion of natural killer (NK) cells in vivo with anti-NK1.1 monoclonal antibody or anti-asialo-GM1 antiserum drastically reduced survival time in Swiss albino mice infected intravenously (i.v.) with herpes simplex virus type 2 (HSV-2). In contrast, depletion of NK cells did not affect the survival time of mice inoculated with HSV-2 by the intraperitoneal route. A single dose of histamine prolonged survival time in animals inoculated with HSV-2 i.v. but not in animals infected intraperitoneally. Treatment with the histamine H2 receptor antagonist ranitidine alone reduced survival time in i.v.-infected animals and blocked the protective effect of histamine. Histamine or ranitidine did not affect survival time in anti-NK1.1- or anti-asialo-GM1-treated animals. Our data suggest a role for histaminergic mechanisms in NK cell-mediated protection against HSV-2.
用抗NK1.1单克隆抗体或抗去唾液酸GM1抗血清在体内耗尽自然杀伤(NK)细胞,会显著缩短经静脉内(i.v.)感染2型单纯疱疹病毒(HSV-2)的瑞士白化小鼠的存活时间。相比之下,耗尽NK细胞并不影响经腹腔途径接种HSV-2的小鼠的存活时间。单剂量组胺可延长经静脉内接种HSV-2的动物的存活时间,但对经腹腔感染的动物无效。单独用组胺H2受体拮抗剂雷尼替丁治疗会缩短经静脉感染动物的存活时间,并阻断组胺的保护作用。组胺或雷尼替丁对经抗NK1.1或抗去唾液酸GM1处理的动物的存活时间没有影响。我们的数据表明组胺能机制在NK细胞介导的抗HSV-2保护中发挥作用。